drug
Imatinib Mesylate CSPC
Marketedupdated 3mo agoby CSPC Pharmaceutical Group Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(0)
nothing on the calendar yet
Trials studying Imatinib Mesylate CSPC
- phase4Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
- phase1A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- phase2Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host
- phase1A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
- phase2Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that